Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

1,752.00p
   
  • Change Today:
      16.00p
  • 52 Week High: 2,774.00
  • 52 Week Low: 1,637.00
  • Currency: UK Pounds
  • Shares Issued: 66.03m
  • Volume: 1,922
  • Market Cap: £1,156.89m
  • RiskGrade: 128

Regulatory News

Total Voting Rights 01-May-2024 13:59 RNS
Interim Results 22-Feb-2024 07:00 RNS
Trading Update 15-Feb-2024 07:00 RNS
Block listing Interim Review 01-Feb-2024 16:24 RNS
Total Voting Rights 01-Feb-2024 16:21 RNS
Non-Executive Director Appointment 12-Dec-2023 07:00 RNS
Result of AGM 22-Nov-2023 13:08 RNS
AGM Trading Update 22-Nov-2023 07:00 RNS
Total Voting Rights 01-Nov-2023 16:46 RNS
Capital Markets Event 01-Nov-2023 07:00 RNS
Annual Report and Annual General Meeting 13-Oct-2023 07:00 RNS
Pos. determination-PRRS resistant pigs-Colombia 05-Oct-2023 10:19 RNS
Total Voting Rights 02-Oct-2023 11:12 RNS
Director/PDMR Shareholding 15-Sep-2023 13:07 RNS
Director/PDMR Shareholding 15-Sep-2023 10:04 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price 1,752.00p
Change Today 16.00p
% Change 0.92 %
52 Week High 2,774.00
52 Week Low 1,637.00
Volume 1,922
Shares Issued 66.03m
Market Cap £1,156.89m
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
95.39% below the market average95.39% below the market average95.39% below the market average95.39% below the market average95.39% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
59.82% below the market average59.82% below the market average59.82% below the market average59.82% below the market average59.82% below the market average
9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average
Income
85.68% below the market average85.68% below the market average85.68% below the market average85.68% below the market average85.68% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
68.04% below the market average68.04% below the market average68.04% below the market average68.04% below the market average68.04% below the market average
48.57% below the sector average48.57% below the sector average48.57% below the sector average48.57% below the sector average48.57% below the sector average

What The Brokers Say

Strong Buy 5
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 7
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Interim Final
Ex-Div 29-Feb-24 09-Nov-23
Paid 28-Mar-24 08-Dec-23
Amount 10.30p 21.70p

Trades for 02-May-2024

Time Volume / Share Price
08:32 2 @ 1,752.00p
08:32 44 @ 1,752.00p
08:32 62 @ 1,752.00p
08:32 47 @ 1,752.00p
08:17 48 @ 1,748.00p

Genus Key Personnel

CFO Alison Henriksen
CEO Jorgen Kokke

Top of Page